Original article
Sunitinib versus pazopanib for patients with metastatic renal cell carcinoma: 2 Turkish hospital experience
Sunitinib versus pazopanib para el tratamiento del carcinoma de células renales metastásico: experiencia en 2 hospitales turcos
Read
142
Timeswas read the article
2
Total PDF
140
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 April | 7 | 0 | 7 |
| 2024 March | 7 | 0 | 7 |
| 2024 February | 10 | 0 | 10 |
| 2024 January | 12 | 0 | 12 |
| 2023 December | 7 | 0 | 7 |
| 2023 November | 10 | 0 | 10 |
| 2023 October | 13 | 1 | 14 |
| 2023 September | 9 | 0 | 9 |
| 2023 August | 8 | 0 | 8 |
| 2023 July | 4 | 0 | 4 |
| 2023 June | 4 | 0 | 4 |
| 2023 May | 4 | 0 | 4 |
| 2023 April | 3 | 0 | 3 |
| 2023 March | 4 | 0 | 4 |
| 2023 February | 4 | 0 | 4 |
| 2023 January | 1 | 0 | 1 |
| 2022 December | 2 | 0 | 2 |
| 2022 November | 2 | 0 | 2 |
| 2022 October | 4 | 0 | 4 |
| 2022 September | 3 | 0 | 3 |
| 2022 August | 2 | 0 | 2 |
| 2022 July | 3 | 0 | 3 |
| 2022 June | 2 | 0 | 2 |
| 2022 May | 2 | 0 | 2 |
| 2022 April | 4 | 0 | 4 |
| 2022 March | 3 | 0 | 3 |
| 2022 February | 4 | 0 | 4 |
| 2022 January | 1 | 0 | 1 |
| 2020 January | 1 | 1 | 2 |
Show all
